# RenovoRx, Inc.: Form 8-K, filed Sep 11, 2023

- Company: [RenovoRx, Inc.](/companies/rnxt.md) (CIK 1574094)
- Form: 8-K
- Filed: 2023-09-11
- Accepted by EDGAR: Sep 8, 2023, 19:41 ET
- Period: 2023-09-07
- Accession: 0001493152-23-032160
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574094/000149315223032160/form8-k.htm

Filed Sep 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-032160. Last ingested by Listed: Nov 6, 2026, 17:30 ET. No prices; not investment advice.
